Jason C Gallagher

2.7k total citations
64 papers, 1.6k citations indexed

About

Jason C Gallagher is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Jason C Gallagher has authored 64 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 24 papers in Infectious Diseases and 24 papers in Pharmacology. Recurrent topics in Jason C Gallagher's work include Antibiotic Use and Resistance (23 papers), Antibiotics Pharmacokinetics and Efficacy (21 papers) and Antibiotic Resistance in Bacteria (20 papers). Jason C Gallagher is often cited by papers focused on Antibiotic Use and Resistance (23 papers), Antibiotics Pharmacokinetics and Efficacy (21 papers) and Antibiotic Resistance in Bacteria (20 papers). Jason C Gallagher collaborates with scholars based in United States, Canada and Hong Kong. Jason C Gallagher's co-authors include Conan MacDougall, Kevin Haynes, John L. Colaizzi, Ruchi Patel, Emily L. Heil, Kaede V. Sullivan, John R. Perfect, Elizabeth S. Dodds Ashley, Safia Kuriakose and Elizabeth Neuner and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Jason C Gallagher

63 papers receiving 1.6k citations

Peers

Jason C Gallagher
Brigid Wilson United States
Melinda M. Neuhauser United States
Michael Postelnick United States
Ronald E. Polk United States
Daryl D. DePestel United States
E. Yoko Furuya United States
Edina Avdic United States
Scott A. Weisenberg United States
Julie Ann Justo United States
Karri A. Bauer United States
Brigid Wilson United States
Jason C Gallagher
Citations per year, relative to Jason C Gallagher Jason C Gallagher (= 1×) peers Brigid Wilson

Countries citing papers authored by Jason C Gallagher

Since Specialization
Citations

This map shows the geographic impact of Jason C Gallagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason C Gallagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason C Gallagher more than expected).

Fields of papers citing papers by Jason C Gallagher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason C Gallagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason C Gallagher. The network helps show where Jason C Gallagher may publish in the future.

Co-authorship network of co-authors of Jason C Gallagher

This figure shows the co-authorship network connecting the top 25 collaborators of Jason C Gallagher. A scholar is included among the top collaborators of Jason C Gallagher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason C Gallagher. Jason C Gallagher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kufel, Wesley D., Conan MacDougall, Samuel L Aitken, et al.. (2025). Antimicrobial Stewardship and Beyond: The Many Essential Roles of Infectious Diseases Pharmacists. Clinical Infectious Diseases. 80(5). 992–997. 2 indexed citations
2.
Kufel, Wesley D., Robert W. Seabury, Jason C Gallagher, et al.. (2024). Let's Have a Chat: How Well Does an Artificial Intelligence Chatbot Answer Clinical Infectious Diseases Pharmacotherapy Questions?. Open Forum Infectious Diseases. 11(11). ofae641–ofae641. 5 indexed citations
3.
McCreary, Erin K., Melissa D. Johnson, Travis Jones, et al.. (2023). Antibiotic Myths for the Infectious Diseases Clinician. Clinical Infectious Diseases. 77(8). 1120–1125. 15 indexed citations
4.
Gallagher, Jason C, et al.. (2023). 225. Dalbavancin Usage in Patients Who Inject Drugs (PWID). Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
5.
Howard‐Anderson, Jessica, Michelle Earley, Lauren Komarow, et al.. (2022). Poor outcomes in both infection and colonization with carbapenem-resistant Enterobacterales. Infection Control and Hospital Epidemiology. 43(12). 1840–1846. 6 indexed citations
6.
Sullivan, Kaede V., Jason C Gallagher, Surbhi Leekha, et al.. (2021). Use of diagnostic and antimicrobial stewardship practices to improve Clostridioides difficile testing among SHEA Research Network hospitals. Infection Control and Hospital Epidemiology. 43(7). 930–934. 7 indexed citations
7.
Ferry, Tristan, Thomas P. Lodise, Jason C Gallagher, et al.. (2020). Outpatient Subcutaneous Antimicrobial Therapy (OSCAT) as a Measure to Improve the Quality and Efficiency of Healthcare Delivery for Patients With Serious Bacterial Infections. Frontiers in Medicine. 7. 585658–585658. 10 indexed citations
8.
Cho, Jonathan C., et al.. (2019). Learning Experiences Within Infectious Diseases Pharmacy Residency Programs in the United States: A Cross-Sectional Survey. Open Forum Infectious Diseases. 6(10). ofz387–ofz387. 5 indexed citations
10.
Sullivan, Kaede V., et al.. (2018). The Epidemiology, Evolution, and Treatment of KPC-Producing Organisms. Current Infectious Disease Reports. 20(6). 13–13. 52 indexed citations
11.
Phillips, Jennifer, et al.. (2016). Student Characteristics Associated with Successful Matching to a PGY1 Residency Program. American Journal of Pharmaceutical Education. 80(5). 84–84. 36 indexed citations
12.
Gallagher, Jason C, et al.. (2015). Clinical and Economic Benefits of Fidaxomicin Compared to Vancomycin for Clostridium difficile Infection. Antimicrobial Agents and Chemotherapy. 59(11). 7007–7010. 47 indexed citations
13.
Gubbins, Paul O., Scott T. Micek, Melissa E. Badowski, et al.. (2014). Innovation in Clinical Pharmacy Practice and Opportunities for Academic–Practice Partnership. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 34(5). e45–54. 30 indexed citations
14.
Justo, Julie Ann, Timothy P. Gauthier, Marc H. Scheetz, et al.. (2014). Knowledge and Attitudes of Doctor of Pharmacy Students Regarding the Appropriate Use of Antimicrobials. Clinical Infectious Diseases. 59(suppl_3). S162–S169. 65 indexed citations
15.
Shord, Stacy S., Terry L. Schwinghammer, Melissa E. Badowski, et al.. (2013). Desired Professional Development Pathways for Clinical Pharmacists. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 33(4). e34–42. 25 indexed citations
16.
Gallagher, Jason C & Anna M. Jackson. (2010). How to write a curriculum vitae. American Journal of Health-System Pharmacy. 67(6). 446–447. 10 indexed citations
17.
Gallagher, Jason C, et al.. (2009). Drug Fever. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(1). 57–69. 105 indexed citations
18.
Gallagher, Jason C, et al.. (2009). Daptomycin Therapy for Vancomycin‐Resistant Enterococcal Bacteremia: A Retrospective Case Series of 30 Patients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(7). 792–799. 39 indexed citations
19.
Gallagher, Jason C. (2008). Comparison of Linezolid (LZD) and Daptomycin (DAP) for Vancomycin-Resistant Enterococcus Bacteremia (VREB). 46th Annual Meeting. 2 indexed citations
20.
Gallagher, Jason C, Conan MacDougall, Elizabeth S. Dodds Ashley, & John R. Perfect. (2004). Recent advances in antifungal pharmacotherapy for invasive fungal infections. Expert Review of Anti-infective Therapy. 2(2). 253–268. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026